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Abstract Patients with severe critical limb ischemia
(CLI) due to long tibial artery occlusions are often poor
candidates for surgical revascularization and frequently
end up with a lower limb amputation. Subintimal angio-
plasty (SA) offers a minimally invasive alternative for limb
salvage in this severely compromised patient population.
The objective of this study was to evaluate the results of
SA in patients with CLI caused by long tibial occlusions
who have no surgical options for revascularization and are
facing amputation. We retrospectively reviewed all con-
secutive patients with CLI due to long tibial occlusions
who were scheduled for amputation because they had no
surgical options for revascularization and who were treated
by SA. A total of 26 procedures in 25 patients (14 males;
mean age, 70 ± 15 [SD] years) were evaluated. Technical
success rate was 88% (23/26). There were four complica-
tions, which were treated conservatively. Finally, in 10 of
26 limbs, no amputation was needed. A major amputation
was needed in 10 limbs (7 below-knee amputations and 3
above-knee amputations). Half of the major amputations
took place within 3 months after the procedure. Cumula-
tive freedom of major amputation after 12 months was
59% (SE = 11%). In six limbs, amputation was limited to
a minor amputation. Seven patients (28%) died during
follow-up. In conclusion, SA of the tibial arteries seem to
be a valuable treatment option to prevent major amputation
in patients with CLI who are facing amputation due to lack
of surgical options.
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Introduction
Critical limb ischemia (CLI) is a manifestation of severe
peripheral arterial disease, characterized by pain at rest,
nonhealing ulcers, or both. Revascularization is necessary
to save the limb and this can be performed surgically or
percutaneously [1]. When both treatments are possible,
endovascular therapy is preferred because of similar clin-
ical outcomes and lower costs [2].
Percutaneous angioplasty of the infrapopliteal arteries
has long been regarded as a difﬁcult procedure because of
the small caliber of the tibial arteries and the tendency to
develop spasm [3, 4]. Over the years experience with
percutaneous treatment of infrapopliteal disease has grown,
with promising technical and clinical results [5–7]. While
short occlusions can be treated percutaneously, most long
occlusions still require a surgical approach. Subintimal
angioplasty (SA) is a percutaneous alternative to surgery to
overcome long occlusions, when a transluminal approach
would be technically impossible. Although SA of tibial
arteries can result in high limb salvage rates, most studies
do not differentiate between severe and mild ischemia and
do not state whether a surgical option was still available.
As a result, such mixed patient groups show higher limb
salvage rates compared with patients with CLI without a
surgical option for revascularization.
Patients with end-stage CLI with long and multiple tibial
artery occlusions, without options for surgical revascu-
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patients, infrapopliteal SA could be an interesting treat-
ment and a last chance to save the patient’s limb. This
‘percutaneous temporary pedal bypass’ was described
previously [8].
The purpose of this study was to evaluate whether tibial
artery SA in end-stage CLI patients without surgical
options an amputation. As a secondary objective of the
study, we evaluated the inﬂuence of outﬂow on clinical
success.
Methods
Patients
A retrospective review was performed of all consecutive
patients without surgical options for revascularization who
underwent a percutaneous vascular intervention of the
tibial arteries between 1 August 2006 and 31 December
2008. All patients were considered candidates for ampu-
tation due to uncontrollable ischemic rest pain or nonhe-
aling ulcers, necrosis, or gangrene. The indication for
amputation was made by the vascular surgeon, in close
consultation with the interventional radiologist. To conﬁrm
correct patient selection, we reviewed all patients with CLI
who presented at our hospital during the study period to
verify the indication once more with an expert panel con-
sisting of a vascular surgeon (M.K.) and an interventional
radiologist (J.R.). We included only patients with an
absolute indication for amputation, i.e., absence of a suit-
able artery for distal anastomosis. All patients with a
clinical presentation showing an option for healing were
accepted for an attempt at endovascular revascularization.
Only those patients who were having severe gangrene with
deep infection, patients who were septic, and patients with
severe ischemia who were not ambulatory due to other
medical causes underwent primary amputation. All patients
were treated for long and multiple tibial artery occlusions.
Accompanying poor inﬂow due to stenoses in the superﬁ-
cial femoral artery (SFA) was not an exclusion criterion.
These lesions were treated in the same procedure. Risk
factors [9], previous interventions, preintervention vascular
assessment, indication, and length of the treated lesion
were recorded.
During the study period, 14 patients needed a primary
amputation due to severe gangrene with deep infection
without any chance of healing. A total of 25 patients were
included in the study. One patient was successively treated
in both legs, with an interval of 6 months between the two
interventions. Therefore, 26 interventions were analyzed.
Patient characteristics are reported in Table 1. Fourteen
were men and the mean age was 70 ± 15 (SD) years.
Sixty-four percent had diabetes mellitus and renal failure
was present in half of the patients, including four hemod-
ialysis patients (16%). All patients suffered from athero-
sclerotic vascular disease. Most limbs were treated because
of tissue loss (Table 2). The large number of patients with
previous interventions, including contralateral amputation,
highlights the severity of arterial obstructive disease in our
patient group. In total 10 stenoses and 31 occlusions were
treated, of which 3 occlusions and 2 stenoses were located
in the femoral artery. All other lesions were located in the
lower limb. Most of the occlusions were at least 20 cm
long (Table 3).
Table 1 Patient characteristics at assessment (n = 25)
Characteristic Mean (±SD) or n (%)
Gender, male 14 (56%)
Age, year 70.3 (±15.2)
Risk factors
Diabetes mellitus 16 (64%)
Hypertension 18 (72%)
Current or former smoker 14 (56%)
Smoking unknown 9 (36%)
Renal failure 13 (52%)
Hypercholesterolemia 7 (28%)
History of coronary artery disease 4 (16%)
History of stroke 3 (12%)
Note: Hypertension was deﬁned as a diastolic blood pressure
[90 mmHg or being on antihypertensive medication; renal failure
was deﬁned as an elevated creatinine level, [110 lmol/L; and
hypercholesterolemia was deﬁned as an elevated triglyceride level,
[2.00 mmol/L, or an elevated LDL cholesterol level,[4.82 mmol/L
[9]
Table 2 Limb characteristics at assessment (n = 26)
Characteristic Median (range) or n (%)
Fontaine stage
III, rest pain 3 (12%)
IV, nonhealing ulcer 23 (88%)
Ankle pressure (highest; mmHg) 70 (36–135)
Toe pressure (mmHg) 29 (0–67)
Previous vascular intervention, ipsilateral 15 (58%)
Below-knee amputation, contralateral 7 (27%)
Table 3 Length of lesions
Stenoses Occlusions
0–5 cm 3 5
5–10 cm 4 4
10–20 cm 0 3
20–30 cm 3 14
Total reconstruction (tibial–popliteal–femoral) 0 5
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All occlusions were treated by the standard SA technique
under local anesthesia [10]. Antiplatelet drugs and oral
vitamin K antagonist were not discontinued prior to the
intervention. An antegrade puncture of the ipsilateral
common or SFA was performed. The subintimal space was
entered proximal to the occlusion and the occluded seg-
ment was traversed with a 0.035-in. guidewire (Terumo,
Tokyo). After re-entry into the lumen distal of the occlu-
sion, the subintimal space was dilated with a 3-mm, 5-Fr
PTA balloon. The balloon lengths varied from 8 to 22 cm.
Both standard PTA balloons (Opta 5; Cordis Europe,
Johnson & Johnson, Roden, The Netherlands) and high-
pushibility PTA balloons (Reekross catheter; ClearStream
Technologies Ltd., Wexford, Ireland) were used [11]. No
stents were used in the tibial arteries. During the inter-
vention, 5000 IU of heparin was administered. After the
intervention, every patient was prescribed anticoagulant
medication, either an antiplatelet drug or an oral vitamin K
antagonist, if this was already being used for other indi-
cations. If the interventionalist judged the ﬂow after the
procedure to be slow, then also clopidogrel, 75 mg daily
for 3 months, was prescribed. Patients were also treated
with intravenous heparin until they were well set on oral
anticoagulant therapy according to a standardized protocol
[12]. Brieﬂy, the heparin dose was 1000 IU/h and the
duration of administration was dependent on the APTT
value, which was determined 6 h after the procedure. The
target APTT level was 2 times the APTT normal value.
Figure 1 shows the angiograms of a patient before and after
subintimal angioplasty of the popliteal and anterior tibial
artery.
Follow-Up
Clinical follow-up was performed by the vascular surgeon.
Follow-up regimens were left to the surgeon’s discretion
and when clinically indicated. Final study follow-up was
done by contacting the patient’s general practitioner.
End Points
The primary end point was limb salvage. Limb salvage was
deﬁned as freedom from major amputation, i.e., any
amputation above the level of the ankle. Secondary end
points included technical success of the procedure, deﬁned
as\30% ﬁnal residual stenosis measured at the narrowest
point of the vascular lumen, and clinical success, deﬁned as
recovery or stabilization of rest pain or ulcers and freedom
from minor amputation, deﬁned as any transmetatarsal
amputation or amputation of one or more toes. Complica-
tions were classiﬁed as minor and major [13].
To explore any differences in outﬂow between patients
with and those without a major amputation, the before and
after intervention angiograms were retrospectively exam-
ined by two experienced interventional radiologists (with 6
and 23 years of experience, respectively) who were una-
ware of the clinical outcome of the patient. The popliteal to
distal vessels were assessed according to three categories:
0, occlusion; 1, severe vessel wall irregularities and diffuse
narrowing; and 2, no or minor vessel wall irregularities and
a fully patent lumen. Moreover, we recorded outﬂow to the
foot after intervention, whether there was direct ﬂow to the
dorsalis pedis artery, plantar arterial arch, and lateral
plantar artery. In the case of disagreement between the two
radiologists, the images in question were jointly reviewed
and a consensus sought.
Statistical Analysis
Patient characteristics were summarized using descriptive
statistics. We analyzed the entire group as well as the
subgroups based on outcome after intervention (patients
Fig. 1 Angiogram of the lower leg and foot of a patient before (A, B)
and after (C, D) subintimal angioplasty of the popliteal and anterior
tibial artery
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123with a major amputation versus other patients). Patient-
related outcomes, like survival and patient characteristics,
are presented on a per-patient basis. Procedure-related
outcomes, like limb salvage and technical success, are
presented on a per-limb basis. For exploring possible dif-
ferences in inﬂow (whether or not the SFA was treated) and
outﬂow between patients who improved and those who
were amputated, we used the chi-square or Fisher’s exact
test. Survival and limb salvage were calculated using the
Kaplan–Meier method. Agreement between the two radi-
ologists in assessing the angiograms is expressed as
weighted kappa values. Statistical analyses were performed
using SPSS 15.0 software (SPSS Inc., Chicago, IL, USA).
Results
Procedure
All patients were treated by SA for long tibial artery
occlusions. In 11 limbs, a subintimal or transluminal
revascularization of the SFA was also performed. The
intervention was technically successful in 23 of 26 limbs
(88%). Reasons for failure were calciﬁcations that were too
extensive in one patient and lack of peripheral runoff found
for re-entry in two patients. Before intervention, 11 patients
had all three tibial arteries occluded, 14 patients had one
patent tibial artery, and 1 patient had two patent tibial
arteries. After intervention, in 1 patient all three tibial
arteries were still occluded, 13 patients had one patent
tibial artery, and 11 patients had 2 patent tibial arteries. In 1
patient, all three tibial arteries were patent.
Complications
Complications occurred after 4 procedures. There were 4
minor complications; a dissection, a subsequent local
extravasation, and a false aneurysm—all treated conser-
vatively; and a nose bleed, which required insertion of a
tampon. There was one major complication: an acute right-
sided cardiac failure which required a 2-day admission to
the cardiac care unit. Patients were discharged a median of
9 days (range, 0–115 days) after intervention.
The median follow-up was 7 months (range, 43 days–
27 months). No patient was lost to follow-up. Clinical
outcome is shown in Fig. 2. Ten limbs were free of
amputation, 6 limbs required a minor amputation, and 10 a
major amputation. Of the three patients with an unsuc-
cessful procedure, two ended up with a below-knee
amputation and one with a transmetatarsal amputation.
Seven patients (28%) died within 43 days to 13.5 months.
The cause of death was unknown in four patients since no
autopsy was performed, one died of cardiac failure, one
died after a stroke, and one of a sepsis, caused by leg
ulcers. The cumulative limb salvage rate after 12 months
was 59% (SE = 11%), and the cumulative survival after
12 months 69% (SE = 11%). Figure 3 shows the Kaplan–
Meier curves of survival and major amputation. After
1 year 13 patients (52%) were alive with a preserved limb.
The agreement of the two interventional radiologists
regarding assessment of the arteries before and after
treatment was substantial (weighted j = 0.76; 95% conﬁ-
dence interval, 0.71–0.82). Before the procedure, the ves-
sels of patients who underwent a major amputation were
worse than those of patients who improved or who needed
only a minor amputation, with more frequent severe ste-
nosis or occlusion (nonsigniﬁcant). After the procedure,
especially the anterior tibial artery and the dorsalis pedis
26 interventions
major amputation (n = 10)
below-knee (n = 7)
above knee (n = 3)
minor amputations (n = 6)
one toe (n = 1)
two or more toes (n = 1)
trans-metatarsal (n = 4)
unchanged or improved (n = 10)
Fig. 2 Clinical outcome
Fig. 3 Kaplan–Meier limb
salvage (A; 26 limbs) and
survival (B; 25 patients) curves.
SE standard error
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123artery were signiﬁcantly of better quality in the improved
patients (p = 0.059 and p = 0.005, respectively).
Concomitant treatment of SFA lesions was not associ-
ated with improved outcome. On the contrary, some 60%
of patients with a major amputation had a concomitant SFA
revascularization, versus 31% of patients who did not have
a major amputation, although this difference was not sta-
tistically signiﬁcant (p = 0.23).
Improved patients had direct ﬂow to the foot via the
dorsalis pedis artery after the intervention more often
compared to patients who were amputated (Table 4;
p = 0.11, nonsigniﬁcant).
Discussion
In this study, we showed that SA of long tibial occlusions
in patients with severe chronic CLI without surgical
options for revascularization is technically feasible and has
a good clinical success rate. In one-third of patients the
clinical status improved or remained unchanged. A major
amputation was still needed in nearly one-third of the
patients, and a minor amputation in one-fourth. The tech-
nical success of the procedure was high, and there were
only a few complications, which could be treated conser-
vatively. Based on these results, we think that a patient
scheduled for amputation due to end-stage chronic CLI
must always be referred to a vascular interventional spe-
cialist with experience in lower limb SA.
In the present study, outﬂow after intervention was
associated with clinical outcome. Patients whose limb was
saved after intervention more often had direct outﬂow to
the dorsalis pedis artery. There was a trend toward a better
clinical outcome in the case of direct ﬂow to the pedal-
plantar arch after intervention. These results conﬁrm the
importance of adequate outﬂow in both endovascular [10]
and surgical revascularization [1, 14–16] procedures. This
implies that opening of the tibial arteries is not enough; the
intervention should also focus on improvement of outﬂow.
New low-proﬁle balloons and dedicated 0.14-in. guide-
wires, not used in the current study, might help to target
this outﬂow problem. In the present study, we did not
perform additional PTA of the foot arteries. However, due
to very low ﬂow before the intervention, ﬁlling of the foot
arteries was nominal. After treatment, the ﬁlling increased
a lot due to better inﬂow caused by the SA of the tibial
arteries. As a result of this study, we have started using foot
artery PTA or SA to establish adequate outﬂow.
In our study we also found that patients who had
undergone concomitant revascularization of the SFA in the
same session had a worse clinical outcome, possibly indi-
cating that patients with more extensive disease beneﬁt less
from revascularization. The cohort was too small to allow
for a multivariate analysis.
In the few studies reporting on SA of the infrapopliteal
arteries in patients with CLI [5–7, 17, 18], the technical
success rate was high, ranging from 78 to 86%, and com-
parable to our technical success rate (88%). Our compli-
cation rate of 15% (4/26) was also in line with these
studies. One-year limb salvage in our study was 59%,
versus a reported 1-year limb salvage rate ranging from 81
to 94%. This difference probably reﬂects patient selection.
We included only patients with CLI without options for
surgical revascularization requiring amputation. It is
known from a previous study, which included patients who
were both suitable and unsuitable for a surgical bypass, that
unsuitability for surgery was associated with restenosis,
reintervention, or amputation [19].
SA of the tibial arteries must be considered among other
alternative therapies for end-stage CLI patients, such as
spinal cord stimulation [20], treatment with Iloprost [21–
23], and therapeutic angiogenesis with progenitor cells
[24–26].
Some shortcomings of this study should be mentioned.
The retrospective nature of our study results in different
sources of bias. First, selection bias potentially inﬂuenced
our results; we only studied a selected sample of a larger
group of patients with CLI. Second, retrospective data
collection often leads to incomplete data. For example, in
our study, pressure measurements were missing for 10
patients. Therefore, our results cannot be supported by
objective pressure measurements. Also, follow-up was not
performed according to a standard protocol, although we
tried to perform follow-up as completely as possible by
contacting treating physicians or local general practitio-
ners. The lack of a control series is another limitation of
Table 4 Outﬂow to the arteries of the foot after intervention: comparison between patients who improved after treatment (n = 16) and patients
who received a major amputation (n = 10)
Direct ﬂow to dorsalis pedis artery Direct ﬂow to plantar artery Direct ﬂow to pedal-plantar arch
Improved (n = 16) 11 (69%) 2 (13%) 5 (31%)
Amputation (n = 10) 3 (30%) 2 (20%) 0 (0%)
p value 0.11 0.63 0.12
Note: Levels of signiﬁcance calculated by means of Fisher’s exact test
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conclusions.
Currently, there are no guidelines for anticoagulant
therapy after interventions of the tibial arteries. There is
wide consensus that all patients with symptomatic periph-
eral arterial disease should be treated with anticoagulant
therapy [1]. In our study, anticoagulant therapy after the
procedure was not prescribed according to a standard
protocol. All patients were treated at least with aspirin or a
vitamin K antagonist. After the procedure, the interven-
tionalist judged the speed of ﬂow, and when it was assessed
to be slow, clopidogrel, 75 mg daily for 3 months, was
prescribed. Again, due to the small size of the cohort, we
were not able to analyze the inﬂuence of anticoagulant
regimen on outcome.
There were no stents placed in the tibial arteries because
there is no evidence of beneﬁt of stent placement in com-
parison with revascularization only.
In conclusion, subintimal angioplasty of the tibial
arteries seems to be a valuable treatment option to prevent
major amputation in patients with severe CLI without any
surgical bypass options, facing amputation. Taking into
account the short life expectation of this population, sub-
intimal angioplasty must be considered as the last chance to
save the patient’s limb. Crucial for the outcome of this kind
of last-resort procedure is establishing good outﬂow for the
recanalized vessels.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Norgren L, Hiatt WR, Dormandy JA et al (2007) Inter-society
consensus for the management of peripheral arterial disease
(TASC II). Eur J Vasc Endovasc Surg 33(Suppl 1):S1–S75
2. Adam DJ, Beard JD, Cleveland T et al (2005) Bypass versus
angioplasty in severe ischaemia of the leg (BASIL): multicentre,
randomised controlled trial. Lancet 366(9501):1925–1934
3. Bertele ` V, Roncaglioni MC, Pangrazzi J et al (1999) Clinical
outcome and its predictors in 1560 patients with critical leg
ischaemia. Chronic Critical Leg Ischaemia Group. Eur J Vasc
Endovasc Surg 18(5):401–410
4. Marston WA, Davies SW, Armstrong B et al (2006) Natural
history of limbs with arterial insufﬁciency and chronic ulceration
treated without revascularization. J Vasc Surg 44(1):108–114
5. Ingle H, Nasim A, Bolia A et al (2002) Subintimal angioplasty of
isolated infragenicular vessels in lower limb ischemia: long-term
results. J Endovasc Ther 9(4):411–416
6. Vraux H, Bertoncello N (2006) Subintimal angioplasty of tibial
vessel occlusions in critical limb ischaemia: a good opportunity?
Eur J Vasc Endovasc Surg 32(6):663–667
7. Met R, Van Lienden KP, Koelemay MJ et al (2008) Subintimal
angioplasty for peripheral arterial occlusive disease: a systematic
review. CardioVasc Interv Radiol 31(4):687–697
8. Reekers JA (2007) The feasibility of a percutaneous temporary
pedal bypass. Eur J Vasc Endovasc Surg 34(1):50–52
9. Rutherford RB, Baker JD, Ernst C et al (1997) Recommend
standards for reports dealing with lower extremity ischemia:
revised version. J Vasc Surg 26(3):517–538
10. Reekers JA, Bolia AM (1998) Percutaneous intentional extralu-
minal (subintimal) recanalization: how to do it yourself. Eur J
Radiol 28(3):192–198
11. Spaargaren GJ, Lee MJ, Reekers JA et al (2009) Evaluation of a
new balloon catheter for difﬁcult calciﬁed lesions in infrainguinal
arterial disease: outcome of a multicenter registry. CardioVasc
Interv Radiol 32(1):132–135
12. Hirsch J, Warkentin TE, Raschke R et al (1998) Heparin and low
molecular weight heparin. Chest 114(5):S489–S510
13. Sacks D, Marinelli DL, Martin LG et al (2003) Reporting stan-
dards for clinical evaluation of new peripheral arterial revascu-
larization devices. J Vasc Interv Radiol 14(9; Pt 2):S395–S404
14. Paty PSK, Darling RCIII, Kreienberg PB et al (1998) Determi-
nants of peroneal artery bypass failure. Vasc Endovasc Surg
32(6):603–608
15. Biancari F, Alba ¨ck A, Ihlberg L et al (1999) Angiographic runoff
score as a predictor of outcome following femorocrural bypass
surgery. Eur J Vasc Endovasc Surg 17(6):480–485
16. Desai TR, Meyerson SL, Skelly CL et al (2001) Patency and limb
salvage after infrainguinal bypass with severely compromised
(‘‘blind’’) outﬂow. Arch Surg 136(6):635–642
17. Vraux H, Hammer F, Verhelst R et al (2000) Subintimal angio-
plasty of tibial vessel occlusions in the treatment of critical limb
ischaemia: mid-term results. Eur J Vasc Endovasc Surg
20(5):441–446
18. Nydahl S, Hartshorne T, Bell PR et al (1997) Subintimal angio-
plasty of infrapopliteal occlusions in critically ischaemic limbs.
Eur J Vasc Endovasc Surg 14(3):212–216
19. Giles KA, Pomposelli FB, Hamdan AD et al (2008) Infrapopliteal
angioplasty for critical limb ischemia: relation of TransAtlantic
InterSociety Consensus class to outcome in 176 limbs. J Vasc
Surg 48(1):128–136
20. Ubbink DT, Vermeulen H, Spincemaille GH et al (2004) Sys-
tematic review and meta-analysis of controlled trials assessing
spinal cord stimulation for inoperable critical leg ischaemia. Br J
Surg 91(8):948–955
21. U.K. Severe Limb Ischaemia Study Group (1991) Treatment of
limb threatening ischaemia with intravenous iloprost: a random-
ised double-blind placebo controlled study. Eur J Vasc Surg
5(5):511–516
22. Norgren L, Alwmark A, Angqvist KA et al (1990) A stable
prostacyclin analogue (iloprost) in the treatment of ischaemic
ulcers of the lower limb. A Scandinavian-Polish placebo con-
trolled, randomised multicenter study. Eur J Vasc Surg 4(5):463–
467
23. The Oral Iloprost in Severe Leg Ischaemia Study Group (2000)
Two randomised and placebo-controlled studies of an oral pros-
tacyclin analogue (Iloprost) in severe leg ischaemia. Eur J Vasc
Endovasc Surg 20(4):358–362
24. Sprengers RW, Lips DJ, Moll FL et al (2008) Progenitor cell
therapy in patients with critical limb ischemia without surgical
options. Ann Surg 247(3):411–420
25. Tateishi-Yuyama E, Matsubara H, Murohara T et al (2002)
Therapeutic angiogenesis for patients with limb ischaemia by
autologous transplantation of bone-marrow cells: a pilot study
and a randomised controlled trial. Lancet 360(9331):427–435
26. Huang P, Li S, Han M et al (2005) Autologous transplantation of
granulocyte colony-stimulating factor-mobilized peripheral blood
mononuclear cells improves critical limb ischemia in diabetes.
Diabetes Care 28(9):2155–2160
474 R. Met et al.: Angioplasty to Prevent Amputation
123